Randomized, Open-label, Controlled Trial of Immediate Postpartum Versus Interval Insertion of Mirena to Increase the Usage at 6 Months After Delivery.
Phase of Trial: Phase IV
Latest Information Update: 04 Dec 2017
At a glance
- Drugs Levonorgestrel (Primary)
- Indications Pregnancy
- Focus Therapeutic Use
- Acronyms MISTIC
- 01 Dec 2012 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 08 Jun 2012 Planned End Date changed from 1 Jun 2011 to 1 Dec 2011 as reported by ClinicalTrials.gov.
- 17 Jan 2011 New trial record